Rutgers begins Pfizer COVID-19 vaccine trial for children ages 5-11

Interview with Dr. Sunanda Gaur, who is leading that work

As the state shifts focus in distribution of COVID-19 vaccines, pediatricians and family practices are on the list to receive doses. According to the state Department of Health, 180 primary care practices have been selected to administer the vaccine, out of more than 1,000 practices that requested them. This is all in preparation for getting more shots in the arms of adolescents age 12 and older, who now are authorized for the Pfizer vaccine; the drug company this week said it expects to request federal authorization by the fall to immunize kids ages 5 to 11 and not long after that for those who are younger.

Rutgers Robert Wood Johnson Medical School is home to New Jersey’s only clinical trial site for the global Pfizer-BioNTech study, testing the COVID-19 vaccine in that 5- to 11-year-old group. The trial started June 7. Dr. Sunanda Gaur is leading that work as a professor of pediatrics and the director of the clinical research center at the medical school.

WATCH: Pediatric ICU director on uptick in adolescent COVID-19 cases and CDC push for teen vaccinations

MORE: With shots widely available, who’s not getting the vaccine?